Improved 5‐year survival with robot‐assisted resection for locally advanced rectal cancer compared to laparoscopic and open surgery: A real‐world cohort study
Colorectal Disease · 2025
DOI: 10.1111/codi.70278 ↗At a glance
Vergleichsstudie in Colorectal Disease, 2025. Written by Marie Hanaoka and 7 co-authors. Institution: Department of Gastrointestinal Surgery, Institute of Science Tokyo, Bunkyo-ku, Tokyo, Japan. Major MEDLINE topics: Laparoscopy, Proctectomy, Rectal Neoplasms, Robotic Surgical Procedures. Cited 11 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Aim
Robot‐assisted rectal cancer surgery offers short‐term benefits; however, data on its long‐term outcomes are lacking. In this study, we aimed to compare the short‐ and long‐term outcomes of open, laparoscopic and robot‐assisted rectal resection (ORR, LRR and RARR) for locally advanced rectal cancer using a large real‐world database.
Methods
This multi‐centre retrospective cohort study analysed 37,191 patients with clinical T3/T4a rectal cancer from the Japanese Medical Data Vision database (2018–2024). After overlap weighting for baseline balance, the effective sample size was 14,627. The primary outcomes were 5‐year overall survival (OS) and relapse‐free survival (RFS). The secondary outcomes included peri‐operative outcomes.
Results
After overlap weighting, the total number of patients was 2247, 10,339 and 2041 in the RARR, LRR and ORR groups, respectively. The mean age was 70 years, and 66% were male. The RARR group had the lowest post‐operative complication rate (17%), shortest duration of hospital stay (16 days) and lowest 90‐day mortality rate and total hospitalisation cost; and the highest 5‐year OS (94%) and 5‐year RFS (93%) compared with the LRR (5‐year OS: 86%, 5‐year RFS: 83%; p < 0.001) and ORR (5‐year OS: 78%, 5‐year RFS: 74%; p < 0.001) groups. RARR was significantly associated with improved OS, whereas higher risks were observed for LRR (hazard ratio [HR]: 2.50) and ORR (HR: 4.69).
Conclusion
Robot‐assisted surgery demonstrated superior short‐ and long‐term outcomes and the lowest total hospitalisation cost compared with other approaches. These results demonstrate the potential of robot‐assisted surgery as a new standard of treatment for locally advanced rectal cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Gastrointestinal Surgery, Institute of Science Tokyo, Bunkyo-ku, Tokyo, Japan.
- Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
- Health Economics and Outcomes Research, Intuitive Surgical Inc, Sunnyvale, California, USA.
ORCID profiles: Marie Hanaoka, Hiroyasu Kagawa
Cite
APA
Hanaoka, M., Kagawa, H., Igarashi, A., Yoshihara, H., Yamauchi, S., Lin, P. L., Shin, M., & Kinugasa, Y. (2025). Improved 5‐year survival with robot‐assisted resection for locally advanced rectal cancer compared to laparoscopic and open surgery: A real‐world cohort study. Colorectal Disease. https://doi.org/10.1111/codi.70278
Vancouver
Hanaoka M, Kagawa H, Igarashi A, Yoshihara H, Yamauchi S, Lin PL, et al. Improved 5‐year survival with robot‐assisted resection for locally advanced rectal cancer compared to laparoscopic and open surgery: A real‐world cohort study. Colorectal Disease. 2025. doi:10.1111/codi.70278
BibTeX
@article{Hanaoka2025,
author = {Hanaoka, Marie and Kagawa, Hiroyasu and Igarashi, Ataru and Yoshihara, Hiroshi and Yamauchi, Shinichi and Lin, Peng-Lin and Shin, Minkyung and Kinugasa, Yusuke},
title = {Improved 5‐year survival with robot‐assisted resection for locally advanced rectal cancer compared to laparoscopic and open surgery: A real‐world cohort study},
journal = {Colorectal Disease},
year = {2025},
doi = {10.1111/codi.70278}
}
EUVIMED